Author | Neil P. Shah, MD, PhD | OncLive

Author | Neil P. Shah, MD, PhD

Articles

Dr. Shah on TKI Treatment Discontinuation in CML

April 24, 2019

Video

Neil P. Shah, MD, PhD, professor of medicine, Division of Hematology and Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses TKI treatment discontinuation in patients with chronic myeloid leukemia.

x